Fabros, Loreta .
HRN: 23-01-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2023
LEVOFLOXACIN 500MG (TAB)
06/10/2023
06/16/2023
PO
500mg
OD
CAP MR, UTI
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes